CA2422305C - Assessing colorectal cancer - Google Patents
Assessing colorectal cancer Download PDFInfo
- Publication number
- CA2422305C CA2422305C CA2422305A CA2422305A CA2422305C CA 2422305 C CA2422305 C CA 2422305C CA 2422305 A CA2422305 A CA 2422305A CA 2422305 A CA2422305 A CA 2422305A CA 2422305 C CA2422305 C CA 2422305C
- Authority
- CA
- Canada
- Prior art keywords
- seq
- genes
- expression
- gene
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 208000001333 Colorectal Neoplasms Diseases 0.000 title claims abstract description 36
- 206010009944 Colon cancer Diseases 0.000 title claims abstract description 33
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 159
- 230000014509 gene expression Effects 0.000 claims abstract description 89
- 238000000034 method Methods 0.000 claims abstract description 45
- 238000002493 microarray Methods 0.000 claims abstract description 23
- 238000011282 treatment Methods 0.000 claims description 12
- 210000001072 colon Anatomy 0.000 claims description 9
- 150000007523 nucleic acids Chemical group 0.000 claims description 9
- 239000011159 matrix material Substances 0.000 claims description 7
- 230000003827 upregulation Effects 0.000 claims description 7
- 230000003828 downregulation Effects 0.000 claims description 6
- 230000004044 response Effects 0.000 claims description 4
- 210000002966 serum Anatomy 0.000 claims description 4
- 239000003153 chemical reaction reagent Substances 0.000 claims description 3
- 102000000820 Enterotoxin Receptors Human genes 0.000 claims description 2
- 108010001687 Enterotoxin Receptors Proteins 0.000 claims description 2
- 210000004369 blood Anatomy 0.000 claims description 2
- 239000008280 blood Substances 0.000 claims description 2
- 230000007423 decrease Effects 0.000 claims description 2
- 108091034117 Oligonucleotide Proteins 0.000 claims 1
- 239000000427 antigen Substances 0.000 claims 1
- 108091007433 antigens Proteins 0.000 claims 1
- 102000036639 antigens Human genes 0.000 claims 1
- 239000002299 complementary DNA Substances 0.000 claims 1
- 238000010208 microarray analysis Methods 0.000 claims 1
- 239000000439 tumor marker Substances 0.000 claims 1
- 241000282414 Homo sapiens Species 0.000 description 33
- 108020004635 Complementary DNA Proteins 0.000 description 31
- 239000000523 sample Substances 0.000 description 31
- 206010028980 Neoplasm Diseases 0.000 description 26
- 210000004027 cell Anatomy 0.000 description 25
- 238000005259 measurement Methods 0.000 description 16
- 210000001519 tissue Anatomy 0.000 description 14
- 108020004999 messenger RNA Proteins 0.000 description 11
- 230000001105 regulatory effect Effects 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 102000004169 proteins and genes Human genes 0.000 description 9
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 230000002068 genetic effect Effects 0.000 description 8
- 239000013610 patient sample Substances 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 201000011510 cancer Diseases 0.000 description 7
- 238000005457 optimization Methods 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 238000004422 calculation algorithm Methods 0.000 description 6
- 238000003745 diagnosis Methods 0.000 description 6
- 108090000765 processed proteins & peptides Proteins 0.000 description 6
- 206010006187 Breast cancer Diseases 0.000 description 5
- 208000026310 Breast neoplasm Diseases 0.000 description 5
- 102100025475 Carcinoembryonic antigen-related cell adhesion molecule 5 Human genes 0.000 description 5
- 238000003556 assay Methods 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 238000012544 monitoring process Methods 0.000 description 5
- 210000005259 peripheral blood Anatomy 0.000 description 5
- 239000011886 peripheral blood Substances 0.000 description 5
- 239000002243 precursor Substances 0.000 description 5
- 238000002560 therapeutic procedure Methods 0.000 description 5
- 101000914321 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 7 Proteins 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 230000001605 fetal effect Effects 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 239000003550 marker Substances 0.000 description 4
- 230000035772 mutation Effects 0.000 description 4
- 238000012340 reverse transcriptase PCR Methods 0.000 description 4
- 229910001868 water Inorganic materials 0.000 description 4
- 201000009030 Carcinoma Diseases 0.000 description 3
- 208000037051 Chromosomal Instability Diseases 0.000 description 3
- 101000914324 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 5 Proteins 0.000 description 3
- 108010050808 Procollagen Proteins 0.000 description 3
- 208000009956 adenocarcinoma Diseases 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 210000002919 epithelial cell Anatomy 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 210000004877 mucosa Anatomy 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 238000004393 prognosis Methods 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 238000000528 statistical test Methods 0.000 description 3
- 102100037965 60S ribosomal protein L21 Human genes 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 108010022366 Carcinoembryonic Antigen Proteins 0.000 description 2
- 102000029792 Desmoplakin Human genes 0.000 description 2
- 108091000074 Desmoplakin Proteins 0.000 description 2
- 102000016359 Fibronectins Human genes 0.000 description 2
- 108010067306 Fibronectins Proteins 0.000 description 2
- 102100032822 Homeodomain-interacting protein kinase 1 Human genes 0.000 description 2
- 101001066404 Homo sapiens Homeodomain-interacting protein kinase 1 Proteins 0.000 description 2
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 2
- 206010061535 Ovarian neoplasm Diseases 0.000 description 2
- 102000013275 Somatomedins Human genes 0.000 description 2
- 238000000692 Student's t-test Methods 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000030279 gene silencing Effects 0.000 description 2
- 238000012226 gene silencing method Methods 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000012775 microarray technology Methods 0.000 description 2
- 238000001558 permutation test Methods 0.000 description 2
- 238000000513 principal component analysis Methods 0.000 description 2
- 210000001525 retina Anatomy 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- WZUVPPKBWHMQCE-XJKSGUPXSA-N (+)-haematoxylin Chemical compound C12=CC(O)=C(O)C=C2C[C@]2(O)[C@H]1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-XJKSGUPXSA-N 0.000 description 1
- 101710187789 60S ribosomal protein L21 Proteins 0.000 description 1
- 102100033936 AP-3 complex subunit beta-1 Human genes 0.000 description 1
- 101710165439 AP-3 complex subunit beta-1 Proteins 0.000 description 1
- 102000008102 Ankyrins Human genes 0.000 description 1
- 108010049777 Ankyrins Proteins 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 108010003721 Calcium-Calmodulin-Dependent Protein Kinase Type 2 Proteins 0.000 description 1
- 102000003846 Carbonic anhydrases Human genes 0.000 description 1
- 108090000209 Carbonic anhydrases Proteins 0.000 description 1
- 102100025474 Carcinoembryonic antigen-related cell adhesion molecule 7 Human genes 0.000 description 1
- 206010007278 Carcinoid tumour of the caecum Diseases 0.000 description 1
- 206010052360 Colorectal adenocarcinoma Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 102100021934 Cyclin-D1-binding protein 1 Human genes 0.000 description 1
- 102100024398 DCC-interacting protein 13-beta Human genes 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 102100034157 DNA mismatch repair protein Msh2 Human genes 0.000 description 1
- 102100021147 DNA mismatch repair protein Msh6 Human genes 0.000 description 1
- 102000007055 Endothelin-3 Human genes 0.000 description 1
- 108010072844 Endothelin-3 Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 101000914063 Eucalyptus globulus Leafy/floricaula homolog FL1 Proteins 0.000 description 1
- 102100036144 FLYWCH-type zinc finger-containing protein 1 Human genes 0.000 description 1
- 102100027297 Fatty acid 2-hydroxylase Human genes 0.000 description 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Natural products C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 1
- 101000897488 Homo sapiens Cyclin-D1-binding protein 1 Proteins 0.000 description 1
- 101001053257 Homo sapiens DCC-interacting protein 13-beta Proteins 0.000 description 1
- 101001134036 Homo sapiens DNA mismatch repair protein Msh2 Proteins 0.000 description 1
- 101000968658 Homo sapiens DNA mismatch repair protein Msh6 Proteins 0.000 description 1
- 101000877395 Homo sapiens ETS-related transcription factor Elf-1 Proteins 0.000 description 1
- 101100335656 Homo sapiens FLYWCH1 gene Proteins 0.000 description 1
- 101000937693 Homo sapiens Fatty acid 2-hydroxylase Proteins 0.000 description 1
- 101100512252 Homo sapiens MAGI3 gene Proteins 0.000 description 1
- 101100346192 Homo sapiens MPC1 gene Proteins 0.000 description 1
- 101000738901 Homo sapiens PMS1 protein homolog 1 Proteins 0.000 description 1
- 101000707247 Homo sapiens Protein Shroom3 Proteins 0.000 description 1
- 101000654674 Homo sapiens Semaphorin-6A Proteins 0.000 description 1
- 101000825904 Homo sapiens Structural maintenance of chromosomes protein 5 Proteins 0.000 description 1
- 101000881764 Homo sapiens Transcription elongation factor 1 homolog Proteins 0.000 description 1
- 101000825182 Homo sapiens Transcription factor Spi-B Proteins 0.000 description 1
- 101100483382 Homo sapiens UBE2J1 gene Proteins 0.000 description 1
- 101000869392 Homo sapiens UDP-N-acetylglucosamine/UDP-glucose/GDP-mannose transporter Proteins 0.000 description 1
- 101000869390 Homo sapiens UDP-glucuronic acid/UDP-N-acetylgalactosamine transporter Proteins 0.000 description 1
- 102100039872 Inner centromere protein Human genes 0.000 description 1
- 101710162819 Inner centromere protein Proteins 0.000 description 1
- 229910015837 MSH2 Inorganic materials 0.000 description 1
- 208000035346 Margins of Excision Diseases 0.000 description 1
- 102100028327 Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3 Human genes 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 206010027480 Metastatic malignant melanoma Diseases 0.000 description 1
- 208000032818 Microsatellite Instability Diseases 0.000 description 1
- 108010074346 Mismatch Repair Endonuclease PMS2 Proteins 0.000 description 1
- 102100037480 Mismatch repair endonuclease PMS2 Human genes 0.000 description 1
- 102100024828 Mitochondrial pyruvate carrier 1 Human genes 0.000 description 1
- 108010026664 MutL Protein Homolog 1 Proteins 0.000 description 1
- 102000013609 MutL Protein Homolog 1 Human genes 0.000 description 1
- 101710138296 NADPH oxidoreductase Proteins 0.000 description 1
- 238000000636 Northern blotting Methods 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 241000143392 Oar Species 0.000 description 1
- 102100037482 PMS1 protein homolog 1 Human genes 0.000 description 1
- 108700001094 Plant Genes Proteins 0.000 description 1
- 102100031747 Protein Shroom3 Human genes 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 108091006629 SLC13A2 Proteins 0.000 description 1
- 102100032795 Semaphorin-6A Human genes 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 102100022773 Structural maintenance of chromosomes protein 5 Human genes 0.000 description 1
- 101710137500 T7 RNA polymerase Proteins 0.000 description 1
- 102100037116 Transcription elongation factor 1 homolog Human genes 0.000 description 1
- 102100022281 Transcription factor Spi-B Human genes 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 102000044209 Tumor Suppressor Genes Human genes 0.000 description 1
- 108700025716 Tumor Suppressor Genes Proteins 0.000 description 1
- 102100032285 UDP-N-acetylglucosamine/UDP-glucose/GDP-mannose transporter Human genes 0.000 description 1
- 102100032284 UDP-glucuronic acid/UDP-N-acetylgalactosamine transporter Human genes 0.000 description 1
- 102100024860 Ubiquitin-conjugating enzyme E2 J1 Human genes 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000003322 aneuploid effect Effects 0.000 description 1
- 208000036878 aneuploidy Diseases 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 230000008236 biological pathway Effects 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- ZGOVYTPSWMLYOF-QEADGSHQSA-N chembl1790180 Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)NC(=O)[C@H]1NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](C(C)C)NC(=O)[C@H]2CSSC[C@@H](C(N[C@H](CC=3C=CC=CC=3)C(=O)N[C@H](C(=O)N[C@H](CCC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N2)[C@H](C)O)=O)NC(=O)[C@@H]([C@@H](C)O)NC(=O)[C@H](N)CSSC1)C1=CNC=N1 ZGOVYTPSWMLYOF-QEADGSHQSA-N 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 208000029664 classic familial adenomatous polyposis Diseases 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000002380 cytological effect Effects 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000011550 data transformation method Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 239000012502 diagnostic product Substances 0.000 description 1
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000010195 expression analysis Methods 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 238000011223 gene expression profiling Methods 0.000 description 1
- 230000007274 generation of a signal involved in cell-cell signaling Effects 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 210000003917 human chromosome Anatomy 0.000 description 1
- 230000006607 hypermethylation Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 108091005485 macrophage scavenger receptors Proteins 0.000 description 1
- 238000007885 magnetic separation Methods 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 230000001394 metastastic effect Effects 0.000 description 1
- 208000021039 metastatic melanoma Diseases 0.000 description 1
- 206010061289 metastatic neoplasm Diseases 0.000 description 1
- 230000003228 microsomal effect Effects 0.000 description 1
- 230000033607 mismatch repair Effects 0.000 description 1
- 238000000329 molecular dynamics simulation Methods 0.000 description 1
- 230000009456 molecular mechanism Effects 0.000 description 1
- 231100000310 mutation rate increase Toxicity 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000000683 nonmetastatic effect Effects 0.000 description 1
- 238000002966 oligonucleotide array Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 238000003909 pattern recognition Methods 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000003161 ribonuclease inhibitor Substances 0.000 description 1
- 108090000327 ribosomal protein L21 Proteins 0.000 description 1
- 102000014452 scavenger receptors Human genes 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- FZHAPNGMFPVSLP-UHFFFAOYSA-N silanamine Chemical compound [SiH3]N FZHAPNGMFPVSLP-UHFFFAOYSA-N 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- VGTPCRGMBIAPIM-UHFFFAOYSA-M sodium thiocyanate Chemical compound [Na+].[S-]C#N VGTPCRGMBIAPIM-UHFFFAOYSA-M 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36868702P | 2002-03-29 | 2002-03-29 | |
| US60/368,687 | 2002-03-29 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2422305A1 CA2422305A1 (en) | 2003-09-29 |
| CA2422305C true CA2422305C (en) | 2013-07-30 |
Family
ID=28675528
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2422305A Expired - Fee Related CA2422305C (en) | 2002-03-29 | 2003-03-28 | Assessing colorectal cancer |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20030186303A1 (enExample) |
| EP (1) | EP1355151A3 (enExample) |
| JP (2) | JP4354725B2 (enExample) |
| KR (1) | KR100984996B1 (enExample) |
| CN (2) | CN101684500A (enExample) |
| AR (1) | AR039211A1 (enExample) |
| AU (1) | AU2003203561A1 (enExample) |
| BR (1) | BR0303012A (enExample) |
| CA (1) | CA2422305C (enExample) |
| MX (1) | MXPA03002863A (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2475769C (en) * | 2003-08-28 | 2018-12-11 | Veridex, Llc | Colorectal cancer prognostics |
| US20050153352A1 (en) * | 2004-01-09 | 2005-07-14 | Stanley Chang | Cancer specific gene MG20 |
| CA2610709A1 (en) * | 2005-06-06 | 2006-12-14 | Genentech, Inc. | Transgenic models for different genes and their use for gene characterization |
| TW200730825A (en) * | 2005-10-21 | 2007-08-16 | Genenews Inc | Method and apparatus for correlating levels of biomarker products with disease |
| CN101437962A (zh) * | 2006-03-03 | 2009-05-20 | 维里德克斯有限责任公司 | 预测杜克氏b结肠癌复发的分子检测 |
| CN102099485A (zh) * | 2007-10-23 | 2011-06-15 | 临床基因组学有限公司 | 诊断新生物的方法-ⅱ |
| EP2169078A1 (en) | 2008-09-26 | 2010-03-31 | Fundacion Gaiker | Methods and kits for the diagnosis and the staging of colorectal cancer |
| WO2013092960A1 (en) | 2011-12-22 | 2013-06-27 | Fundacion Gaiker | Methods and kits for the diagnosis of colorectal cancer |
| CN102586420B (zh) * | 2011-12-27 | 2014-10-22 | 盛司潼 | 一种检测乳腺癌易感基因的方法及试剂盒 |
| CN102586423B (zh) * | 2011-12-27 | 2015-01-07 | 盛司潼 | 一种检测结直肠癌易感基因的方法及试剂盒 |
| CN115678994B (zh) * | 2022-01-27 | 2025-01-21 | 上海爱谱蒂康生物科技有限公司 | 一种生物标志物组合、含其的试剂及其应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US635152A (en) * | 1899-06-05 | 1899-10-17 | Melancthon S Shotwell | Car-body bolster. |
| US6275814B1 (en) * | 1996-11-27 | 2001-08-14 | Investment Strategies Network | Investment portfolio selection system and method |
| US6003018A (en) * | 1998-03-27 | 1999-12-14 | Michaud Partners Llp | Portfolio optimization by means of resampled efficient frontiers |
| US6350578B1 (en) * | 1999-06-25 | 2002-02-26 | The Regents Of The University Of California | Method of quantitating dsDNA |
| US6175824B1 (en) * | 1999-07-14 | 2001-01-16 | Chi Research, Inc. | Method and apparatus for choosing a stock portfolio, based on patent indicators |
-
2003
- 2003-03-21 US US10/394,382 patent/US20030186303A1/en not_active Abandoned
- 2003-03-28 BR BR0303012-1A patent/BR0303012A/pt not_active IP Right Cessation
- 2003-03-28 CA CA2422305A patent/CA2422305C/en not_active Expired - Fee Related
- 2003-03-28 AU AU2003203561A patent/AU2003203561A1/en not_active Abandoned
- 2003-03-29 KR KR1020030019815A patent/KR100984996B1/ko not_active Expired - Fee Related
- 2003-03-29 CN CN200910175739A patent/CN101684500A/zh active Pending
- 2003-03-29 CN CNA031378714A patent/CN1502989A/zh active Pending
- 2003-03-31 JP JP2003094744A patent/JP4354725B2/ja not_active Expired - Fee Related
- 2003-03-31 EP EP03252024A patent/EP1355151A3/en not_active Withdrawn
- 2003-03-31 MX MXPA03002863A patent/MXPA03002863A/es active IP Right Grant
- 2003-04-01 AR ARP030101132A patent/AR039211A1/es not_active Application Discontinuation
-
2009
- 2009-03-31 JP JP2009086981A patent/JP2009153521A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003203561A1 (en) | 2003-10-23 |
| CA2422305A1 (en) | 2003-09-29 |
| AR039211A1 (es) | 2005-02-09 |
| JP2003325191A (ja) | 2003-11-18 |
| BR0303012A (pt) | 2004-09-08 |
| KR20030078801A (ko) | 2003-10-08 |
| CN1502989A (zh) | 2004-06-09 |
| KR100984996B1 (ko) | 2010-10-04 |
| EP1355151A3 (en) | 2004-08-25 |
| EP1355151A2 (en) | 2003-10-22 |
| CN101684500A (zh) | 2010-03-31 |
| JP4354725B2 (ja) | 2009-10-28 |
| JP2009153521A (ja) | 2009-07-16 |
| US20030186303A1 (en) | 2003-10-02 |
| MXPA03002863A (es) | 2004-08-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1526186B1 (en) | Colorectal cancer prognostics | |
| US8183353B2 (en) | Breast cancer prognostics | |
| US10196691B2 (en) | Colon cancer gene expression signatures and methods of use | |
| EP2982985B1 (en) | System for predicting prognosis of locally advanced gastric cancer | |
| AU2008203227B2 (en) | Colorectal cancer prognostics | |
| EP1888785A2 (en) | Thyroid fine needle aspiration molecular assay | |
| JP2009153521A (ja) | 結腸直腸癌の評価 | |
| JP2009153522A (ja) | 結腸直腸癌の評価 | |
| CN101960022A (zh) | Ⅱ期和ⅲ期结肠癌的分子分期和预后 | |
| US20050186577A1 (en) | Breast cancer prognostics | |
| CA2475769C (en) | Colorectal cancer prognostics |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |
Effective date: 20170328 |